9 Meters Biopharma

9 Meters Biopharma is developing treatments for Celiac disease, an autoimmune gastrointestinal disease characterized by an inflammatory response to dietary gluten, causing abdominal pain and gas that are often severe and life-altering. At a metabolic level, dietary gluten breaks down into gliadin, which disrupts tight junctions between cells in the gut in people with celiac disease. These disruptions enable gliadin to enter systemic circulation and stimulate an inflammatory response.